MRNA Vaccines Impress, Blueprint Wins First FDA OK, & Calif. Gov. Stares Down Biotech on the Eve of #JPM20

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $149 per year, you reward quality independent biotech reporting, and encourage more.


You may also like

The Infodemic Summer
A Glimmer of Hope, and a Premature Celebration
Meet My Friend Who Supported Trump in 2016
Keeping the Faith and Bracing for the Long Slog